TNFSF14 and infection: Thus, the infection of cultured pancreatic adenocarcinoma cells with the vMyx-mLIGHT-FLuc/tdTr construct leads to a marked-to-significant reduction in cell viability, suggesting that oncolytic treatment of even the semi- and non-permissive types of cancers may provide sizeable therapeutic benefits in vivo, as well as still delivering therapeutic proteins such as LIGHT, if expressed under early virus promoter control.